Novel Targets and Therapies for GI Malignancies: What does the future hold?
Novel Targets and Therapies for GI Malignancies: What does the future hold?. David H. Ilson, M.D., Ph.D. GI Oncology Service Memorial Sloan-Kettering Cancer Center New York, NY. GI Cancers: US Incidence in 2013. 292,200 new cases and 144,570 deaths (49%) Case Fatality Rate:
942 views • 71 slides